A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors
Teva Branded Pharmaceutical Products R&D, Inc.
Teva Branded Pharmaceutical Products R&D, Inc.
Sanofi
Ocellaris Pharma, Inc.
Sanofi
NuCana plc
Numab Therapeutics AG
Thomas Jefferson University
Aminex Therapeutics, Inc.
23andMe, Inc.
Teon Therapeutics, Inc.
Takeda
Atara Biotherapeutics
University of California, San Diego
Altor BioScience
Altor BioScience
Altor BioScience
Theseus Pharmaceuticals
Sumitomo Pharma America, Inc.
Shanghai EpimAb Biotherapeutics Co., Ltd.
Kyowa Kirin Co., Ltd.
National Cancer Institute (NCI)
GlaxoSmithKline
SQZ Biotechnologies
Capital Medical University
Teva Branded Pharmaceutical Products R&D, Inc.
University Health Network, Toronto
CytomX Therapeutics
Intellia Therapeutics
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
NBE-Therapeutics AG
Sanofi
Asana BioSciences
4D pharma plc
Bristol-Myers Squibb
Advaxis, Inc.
Bristol-Myers Squibb
GlaxoSmithKline
Swiss Cancer Institute
Molecular Templates, Inc.
Boston Scientific Corporation
Polaris Group
Swiss Cancer Institute
Proximagen, LLC
Bristol-Myers Squibb
Effector Therapeutics
Sunesis Pharmaceuticals
Symphogen A/S
Bristol-Myers Squibb
University of California, San Diego